Xunlei (XNET:NAS) and ASLAN Pharmaceuticals (ASLN:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEA Liberty Expedia Holdings Inc 43.960000 57327005 None 1.0952 65.68 -7.99
LEXEB Liberty Expedia Holdings Inc 42.560000 57327005 None 1.0603 65.68 -7.99
SOHU Sohu.com Ltd 13.810000 39228538 None 1.0121 21.38 12.30
PRTA Prothena Corp PLC 9.090000 39864561 None 1.1610 10.29 10.29
PDLI PDL BioPharma Inc 2.970000 120654947 None 0.5169 3.04 1.99
XNET Xunlei Ltd 2.190000 67438145 None 0.4336 2.32 2.21
ZVO Zovio Inc 3.790000 30217370 34.6471 0.9389 4.69 4.69
ASLN ASLAN Pharmaceuticals Ltd 3.700000 32049788 None 3.8730 27.57 14.24
APTX Aptinyx Inc 3.020000 33562211 None 0.7525 4.07 None
NHTC Natural Health Trends Corp 8.790000 11225326 4.9106 1.1493 10.57 0.13
NVTR Nuvectra Corp 3.630000 17800235 None 0.8122 4.57 2.07
SCPH scPharmaceuticals Inc 3.380000 18580430 2.6622 0.8921 4.49 3.97
AQXP Aquinox Pharmaceuticals Inc 2.380000 23537368 None 0.7830 3.15 3.15
EVK Ever-Glory International Group Inc 3.330000 14800140 4.6901 0.4132 3.91 1.96
TST TheStreet Inc 5.799900 6407273 3.2090 0.3328 18.42 7.18
ALT Altimmune Inc 2.360000 13450680 None 0.5351 3.29 3.25
APWC Asia Pacific Wire & Cable Corp Ltd 2.190900 13819669 10.4329 0.2018 4.40 2.60
KIRK Kirkland’s Inc 2.070000 14164148 17.6250 0.2447 4.09 -1.45
GIGM GigaMedia Ltd 2.320000 11052235 28.0000 0.4449 5.25 5.77
ADXS Advaxis Inc 2.720000 8006984 None 0.5808 4.09 14.08
VLRX Valeritas Holdings Inc 3.490000 5309116 None 12.6563 6.92 -0.90
ONCS OncoSec Medical Inc 2.590000 7121608 None 0.7477 3.44 1.26
MDGS Medigus Ltd 2.400000 3796602 None 1.1278 2.80 None
CHFS CHF Solutions Inc 3.000000 2268320 None 0.5432 5.06 0.58
KBSF KBS Fashion Group Ltd 2.470000 2591299 None 0.1116 7.81 7.38

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

XNET:NAS Xunlei

http://www.xunlei.com
Xunlei has 1165 employees and is headquartered in China.
Xunlei Ltd is an online advertising service provider. It also provides downloading services and online game platforms for game developers and users. Its products and services include Xunlei accelerator and cloud acceleration subscription services.

ASLN:NAS ASLAN Pharmaceuticals

http://www.aslanpharma.com
ASLAN Pharmaceuticals has 56 employees and is headquartered in Singapore.
ASLAN Pharmaceuticals Ltd is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies. Its products include Varlitinib, ASLAN002, ASLAN003, ASLAN004, ASLAN005, and Modybodies.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.